Product Information

PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.2724 per EA under NDC 00228234810. Its NADAC has been published 649 times since Nov 28, 2013.

The Low Outlier badge above means this manufacturer's average price in the Propylthiouracil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PROPYLTHIOURACIL 50 MG TABLET

Propylthiouracil
$0.2724per EA
Discontinued
Low Outlier

Strength

50 mg/1

NDC

00228234810

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PROPYLTHIOURACIL

Approval Type

Generic (ANDA)

FDA Application

ANDA080172

On Market Since

1/15/2006

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2724 per EA
All-time high$0.7308 (May 13, 2015)
All-time low$0.2149 (May 22, 2024)
52-week high$0.3341
52-week low$0.2646
Median price$0.5251
Average price$0.5146
Largest weekly change-44.1% (May 22, 2024)
Weeks tracked649
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

-1.6%

6M

-2.1%

1Y

-18.5%

3Y

-42.5%

5Y

-47.1%

All

-36.8%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.2724 per EA (NDC 00228234810), effective Apr 29, 2026.

How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has declined 36.8%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?

Since Nov 28, 2013, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2149 (May 22, 2024) to a high of $0.7308 (May 13, 2015), with a median of $0.5251 per EA.

Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?

5 NADAC-published products share the same active ingredient, strength, and dosage form as PROPYLTHIOURACIL 50 MG TABLET, but none are currently priced below it.

Who manufactures PROPYLTHIOURACIL 50 MG TABLET?

PROPYLTHIOURACIL 50 MG TABLET (NDC 00228234810) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.